Merck to support Transgene and BioInvent led oncolytic virus clinical trial

Merck to support Transgene and BioInvent led oncolytic virus clinical trial

Submitted by admin on June 28, 2022 - 5:49pm
Source: 
Biopharma Reporter
News Tags: 
Merck
Keytruda
clinical trials
Transgene
Bioinvent
solid tumors
Headline: 
Merck to support Transgene and BioInvent led oncolytic virus clinical trial
snippet: 

MSD will supply Keytruda (pembrolizumab) in a phase 1/2a clinical trial for the treatment of patients with solid tumors, as part of an agreement with Transgene and BioInvent.

Do Not Allow Advertisers to Use My Personal information